Patent · US Expired

Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors

US5595970A · kind A · utility

67Cited by

0References

14Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Robert E. Garfield · Goodyear, US
Krzysztof Chwalisz · Berlin, DE
Radoslaw Bukowski · Berlin, DE
Chandra Yallampalli · Houston, US

Key dates

Filing date	Nov 16, 1993
Grant date	Jan 21, 1997
Priority date	—
Expiry date	Nov 16, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The symptoms of the climacterium are ameliorated by the administration to an afflicted individual one or both of a nitric oxide substrate and/or nitric acid donor, alone or optionally in combination with a progestin or, in the case of a non-pregnant female, either a progestin or an estrogen or both.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.